{
  "drug_name": "Atropine",
  "url": "https://wikem.org/wiki/Atropine",
  "scraped_at": "2026-01-10T07:48:18.065220",
  "sections": {
    "General": {
      "text": "Type:\nAnticholinergic\nRoutes of Administration: IV/IM/IO/SC, endotracheal, nebulized, PO, topical/ophthalmic\nCommon Trade Names: Atropine, Atreza, SalTropine, AtroPen, IsoptoAtropine",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Anticholinergic",
          "url": "https://wikem.org/wiki/Anticholinergic"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Symptomatic_bradyarrhythmia_or_AV_block": {
          "text": "0.5 mg IV rapid push q3-5m (max = 0.04 milligram/kg)",
          "tables": []
        },
        "Cardiac_arrest_(bradyasystolic)": {
          "text": "1mg IV/IM/subQ/endotracheally q3-5m",
          "tables": []
        },
        "Organophosphate_toxicity": {
          "text": "1-3mg IV/IM/SC/endotracheally q10-30m, max 3 doses",
          "tables": []
        },
        "IBS,_PUD": {
          "text": "0.4-0.6 mg PO or IV/IM/SC q4-6h",
          "tables": []
        },
        "Cycloplegia/mydriasis_induction": {
          "text": "1-2 drops of 1% solution 1-3 times daily",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Symptomatic_bradyarrhythmia_or_AV_block": {
      "text": "0.5 mg IV rapid push q3-5m (max = 0.04 milligram/kg)",
      "subsections": {
        "Cardiac_arrest_(bradyasystolic)": {
          "text": "1mg IV/IM/subQ/endotracheally q3-5m",
          "tables": []
        },
        "Organophosphate_toxicity": {
          "text": "1-3mg IV/IM/SC/endotracheally q10-30m, max 3 doses",
          "tables": []
        },
        "IBS,_PUD": {
          "text": "0.4-0.6 mg PO or IV/IM/SC q4-6h",
          "tables": []
        },
        "Cycloplegia/mydriasis_induction": {
          "text": "1-2 drops of 1% solution 1-3 times daily",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Organophosphate_toxicity": {
      "text": "1-3mg IV/IM/SC/endotracheally q10-30m, max 3 doses",
      "subsections": {
        "IBS,_PUD": {
          "text": "0.4-0.6 mg PO or IV/IM/SC q4-6h",
          "tables": []
        },
        "Cycloplegia/mydriasis_induction": {
          "text": "1-2 drops of 1% solution 1-3 times daily",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "IBS,_PUD": {
      "text": "0.4-0.6 mg PO or IV/IM/SC q4-6h",
      "subsections": {
        "Cycloplegia/mydriasis_induction": {
          "text": "1-2 drops of 1% solution 1-3 times daily",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Cycloplegia/mydriasis_induction": {
      "text": "1-2 drops of 1% solution 1-3 times daily",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_dosing": {
      "text": "",
      "subsections": {
        "Symptomatic_bradyarrhythmia_or_AV_block_2": {
          "text": "0.01-0.03 mg/kg IV/IO q1-2h",
          "tables": []
        },
        "Cardiac_arrest_(bradyasystolic)_2": {
          "text": "0.01-0.03 mg/kg IV/IM/subQ/endotracheally",
          "tables": []
        },
        "Organophosphate_toxicity_2": {
          "text": "0.01-0.03 mg/kg IV/IM/subQ/endotracheally",
          "tables": []
        },
        "IBS,_PUD_2": {
          "text": "0.01 mg/kg (max 0.4 mg or 0.3 mg/m2) PO/SC q4-6h",
          "tables": []
        },
        "Cycloplegia/mydriasis_induction_2": {
          "text": "1-2 drops of 1% solution 1-3 times daily",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Symptomatic_bradyarrhythmia_or_AV_block_2": {
      "text": "0.01-0.03 mg/kg IV/IO q1-2h",
      "subsections": {
        "Cardiac_arrest_(bradyasystolic)_2": {
          "text": "0.01-0.03 mg/kg IV/IM/subQ/endotracheally",
          "tables": []
        },
        "Organophosphate_toxicity_2": {
          "text": "0.01-0.03 mg/kg IV/IM/subQ/endotracheally",
          "tables": []
        },
        "IBS,_PUD_2": {
          "text": "0.01 mg/kg (max 0.4 mg or 0.3 mg/m2) PO/SC q4-6h",
          "tables": []
        },
        "Cycloplegia/mydriasis_induction_2": {
          "text": "1-2 drops of 1% solution 1-3 times daily",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Organophosphate_toxicity_2": {
      "text": "0.01-0.03 mg/kg IV/IM/subQ/endotracheally",
      "subsections": {
        "IBS,_PUD_2": {
          "text": "0.01 mg/kg (max 0.4 mg or 0.3 mg/m2) PO/SC q4-6h",
          "tables": []
        },
        "Cycloplegia/mydriasis_induction_2": {
          "text": "1-2 drops of 1% solution 1-3 times daily",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "IBS,_PUD_2": {
      "text": "0.01 mg/kg (max 0.4 mg or 0.3 mg/m2) PO/SC q4-6h",
      "subsections": {
        "Cycloplegia/mydriasis_induction_2": {
          "text": "1-2 drops of 1% solution 1-3 times daily",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Cycloplegia/mydriasis_induction_2": {
      "text": "1-2 drops of 1% solution 1-3 times daily",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation: Infant risk cannot be ruled out\nRenal Dosing: no adjustment\nHepatic Dosing: no adjustment\nIneffective in cardiac transplant patients",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nPrimary glaucoma or predisposition to narrow anterior chamber angle glaucoma",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Cardiac dysrhythmia\n,\ntachyarrhythmia\nIf given slowly or in amounts <0.5mg, may cause paradoxical bradycardia\nIncreased O2 consumption\nHypotension\nComa\nRespiratory depression\nGlaucoma",
          "tables": []
        },
        "Common": {
          "text": "Constipation, xerostomia\nBlurred vision, decreased lacrimation, eye pain, photophobia, superficial keratitis",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Cardiac dysrhythmia",
          "url": "https://wikem.org/wiki/Cardiac_dysrhythmia"
        },
        {
          "text": "tachyarrhythmia",
          "url": "https://wikem.org/wiki/Tachyarrhythmia"
        },
        {
          "text": "Hypotension",
          "url": "https://wikem.org/wiki/Hypotension"
        },
        {
          "text": "Coma",
          "url": "https://wikem.org/wiki/Coma"
        },
        {
          "text": "Glaucoma",
          "url": "https://wikem.org/wiki/Glaucoma"
        }
      ]
    },
    "Serious": {
      "text": "Cardiac dysrhythmia\n,\ntachyarrhythmia\nIf given slowly or in amounts <0.5mg, may cause paradoxical bradycardia\nIncreased O2 consumption\nHypotension\nComa\nRespiratory depression\nGlaucoma",
      "subsections": {
        "Common": {
          "text": "Constipation, xerostomia\nBlurred vision, decreased lacrimation, eye pain, photophobia, superficial keratitis",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Cardiac dysrhythmia",
          "url": "https://wikem.org/wiki/Cardiac_dysrhythmia"
        },
        {
          "text": "tachyarrhythmia",
          "url": "https://wikem.org/wiki/Tachyarrhythmia"
        },
        {
          "text": "Hypotension",
          "url": "https://wikem.org/wiki/Hypotension"
        },
        {
          "text": "Coma",
          "url": "https://wikem.org/wiki/Coma"
        },
        {
          "text": "Glaucoma",
          "url": "https://wikem.org/wiki/Glaucoma"
        }
      ]
    },
    "Common": {
      "text": "Constipation, xerostomia\nBlurred vision, decreased lacrimation, eye pain, photophobia, superficial keratitis",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 2.5 hrs\nMetabolism: hepatic\nExcretion: renal\nOnset of action (IV) = 2-4min\nDuration of action (IV) = 5hr",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Parasympatholytic\nIncreases sinus/AV conduction",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Antiarrhythmics\nCritical care quick reference\nAnticholinergic toxicity",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antiarrhythmics",
          "url": "https://wikem.org/wiki/Antiarrhythmics"
        },
        {
          "text": "Critical care quick reference",
          "url": "https://wikem.org/wiki/Critical_care_quick_reference"
        },
        {
          "text": "Anticholinergic toxicity",
          "url": "https://wikem.org/wiki/Anticholinergic_toxicity"
        }
      ]
    }
  }
}